Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02BE51	HUMEX RHUME	B	Pseudoephedrine HCl (tablet) - 60mg, Paracetamol (tablet) - 500mg, Paracetamol (capsule) - 500mg, Chlorphenamine maleate (capsule) - 4mg		Tablet, capsule	467,657 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	6,048,090 L.L
C03BA04	HYGROTON	B	Chlortalidone - 50mg	50mg	Tablet	422,351 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
M09AX01	HYALGAN	B	Hyaluronic acid (sodium) - 20mg/2ml	20mg/2ml	Injectable solution	3,407,985 L.L
C05BA01	HIRUDOID	B	Mucopolysaccharide Polysulfuric Acid Ester - 3mg/g	3mg/g	Cream	506,629 L.L
C05BA01	HIRUDOID	B	Mucopolysaccharide Polysulfuric Acid Ester - 3mg/g	3mg/g	Gel	368,213 L.L
J07BC02	HAVRIX '1440'	B	Hepatitis A, inactivated, whole virus - 1,440 ELISA units/ml	1,440 ELISA units/ml	Injectable suspension	2,215,996 L.L
J07BC02	HAVRIX JUNIOR 720	B	Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml	720 ELISA units/0.5ml	Injectable suspension	1,491,665 L.L
C09DA01	HYZAAR	B	Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg		Tablet	1,523,022 L.L
C09DA01	HYZAAR	B	Losartan potassium - 100mg, Hydrochlorothiazide - 12.5mg		Tablet	1,740,596 L.L
L01AA06	HOLOXAN	B	Ifosfamide - 1g	1g	Injectable powder for solution	3,586,850 L.L
R02AA20	HEXASPRAY COLLUTOIRE PRESSURISE	B	Biclotymol - 750mg	750mg	Spray	353,431 L.L
H02AB09	HYDROCORTISONE ROUSSEL	B	Hydrocortisone - 10mg	10mg	Tablet, scored	260,705 L.L